93 related articles for article (PubMed ID: 12685854)
1. Clinical significance of CD56 expression in patients with acute myeloid leukemia.
Lee JJ; Chung IJ; Yang DH; Cho SH; Cho D; Ryang DW; Kim HJ
Leuk Lymphoma; 2002 Sep; 43(9):1897-9. PubMed ID: 12685854
[No Abstract] [Full Text] [Related]
2. Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.
Coelho-Silva JL; Carvalho LE; Oliveira MM; Franca-Neto PL; Andrade AT; Lima AS; Bezerra MF; Lima MM; Neves MA; Fonseca JM; Barros-Correia MC; Machado CG; Bezerra MA; Matos DM; Lucena-Araujo AR
Br J Haematol; 2017 Feb; 176(3):498-501. PubMed ID: 26914377
[No Abstract] [Full Text] [Related]
3. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
[TBL] [Abstract][Full Text] [Related]
4. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
Chen C; Chio CL; Zeng H; Li Y
Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CD56 antigen expression in acute myeloid leukemia.
Di Bona E; Sartori R; Zambello R; Guercini N; Madeo D; Rodeghiero F
Haematologica; 2002 Mar; 87(3):250-6. PubMed ID: 11869936
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
9. A near tetraploid clone in acute myeloid leukemia with CD56 expression.
Gundimeda SD; Ahmed F; Mundada MC; Rajappa SJ; Murthy SS
J Cancer Res Ther; 2014; 10(1):187-90. PubMed ID: 24762509
[TBL] [Abstract][Full Text] [Related]
10. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
[TBL] [Abstract][Full Text] [Related]
11. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia.
Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H
Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150
[TBL] [Abstract][Full Text] [Related]
14. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
15. Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes.
Gerber JM; Zeidner JF; Morse S; Blackford AL; Perkins B; Yanagisawa B; Zhang H; Morsberger L; Karp J; Ning Y; Gocke CD; Rosner GL; Smith BD; Jones RJ
Haematologica; 2016 May; 101(5):607-16. PubMed ID: 26819054
[TBL] [Abstract][Full Text] [Related]
16. CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia.
Chen MH; Atenafu E; Craddock KJ; Brandwein J; Chang H
Leuk Res; 2013 Feb; 37(2):122-8. PubMed ID: 23092917
[TBL] [Abstract][Full Text] [Related]
17. NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.
Martner A; Rydström A; Riise RE; Aurelius J; Brune M; Foà R; Hellstrand K; Thorén FB
Oncotarget; 2015 Dec; 6(40):42569-74. PubMed ID: 26544512
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
19. Expression of N-CAM (CD56) on acute leukemia cells: relationship with disease characteristics and outcome.
Thomas X; Vila L; Campos L; Sabido O; Archimbaud E
Leuk Lymphoma; 1995 Oct; 19(3-4):295-300. PubMed ID: 8535222
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
